RenovoRx Inc
RNXT
NASDAQ
Biotechnology
$1.40
USD
+0.14 (+11.11%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $56.77M
Volume 1.0M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
XBIT | XBiotech Inc | $75.00M | - | - | - | |
DWTX | Dogwood Therapeutics Inc | $66.59M | - | - | - | |
MNOV | MediciNova Inc | $65.46M | - | - | - | |
PMVP | PMV Pharmaceuticals Inc | $65.06M | - | - | - | |
TENX | Tenax Therapeutics Inc | $64.93M | - | -82.9% | - | |
HRTX | Heron Therapeutics Inc | $63.49M | - | +1.0% | - | |
BOLD | Boundless Bio Inc | $63.38M | - | - | - | |
INMB | INmune Bio Inc | $58.56M | - | - | - | |
ATYR | aTyr Pharma Inc | $56.90M | - | -19.1% | - | |
RNXT | RenovoRx Inc | $56.77M | - | - | - | |
INKT | Mink Therapeutics Inc | $54.80M | - | - | - | |
XLO | Xilio Therapeutics Inc | $54.14M | - | +476.7% | - |
Top Peer by Growth
Xilio Therapeutics Inc
+476.7% YoY Revenue
Best 1-Year Return
Boundless Bio Inc
+148.2% Return